id: buprenorphine_provider_density_to_population_outside_treatment_access_buffer
name: Buprenorphine Provider Density per 100,000 Population â†’ Population Outside Geographic
  Treatment Access Buffer
from_node:
  node_id: buprenorphine_provider_density
  node_name: Buprenorphine Provider Density per 100,000 Population
to_node:
  node_id: population_outside_treatment_access_buffer
  node_name: Population Outside Geographic Treatment Access Buffer
direction: negative
category: healthcare_access
mechanism_pathway:
- 'Step 1: National provider density of 14.3 per 100,000 persons indicates insufficient
  treatment capacity relative to opioid use disorder prevalence'
- 'Step 2: Low provider density means greater average distance between any given location
  and nearest provider'
- 'Step 3: Populations in areas with lowest provider density face longest travel distances
  and greatest access barriers'
- 'Step 4: Geographic access barriers translate to reduced treatment initiation and
  retention'
evidence:
  quality_rating: C
  n_studies: 1
  primary_citation: James R Langabeer et al. 2020. "Geographic proximity to buprenorphine
    treatment providers in the U.S.." *Drug and alcohol dependence*. https://doi.org/10.1016/j.drugalcdep.2020.108131
last_updated: '2025-12-02'
version: '1.0'
llm_metadata:
  extracted_by: claude-sonnet-4-5-20250929
  extraction_date: '2025-12-02T18:12:07.499716'
  batch_id: msgbatch_01AKnPJgzm7Fk9qubgAz9GaD
moderators:
- name: state_opioid_use_disorder_prevalence
  direction: strengthens
  strength: moderate
  description: Areas of higher treatment need have lower access, suggesting provider
    density is inversely related to population need in some regions
_source_file: /Users/mauriceelhelou/Library/CloudStorage/OneDrive-HarvardUniversity/New
  folder (2)/healthsystems/mechanism-bank/mechanisms/healthcare_access/buprenorphine_provider_density_to_population_outside_treatment_access_buffer.yaml
_category: healthcare_access
